Suchergebnisse - "Yokoyama, Keitaro"

PubPharm (317)

71

An introduction to CKD-MBD research : restart for the future

enthalten in: Clinical and experimental nephrology | 2017

von Fukagawa, M. | Inaba, M. | Yokoyama, K. | +8

72

Frequent monitoring of mineral metabolism in hemodialysis patients with secondary hyperparathyroidism : associations with achievement of treatment goals and with adjustments in therapy

enthalten in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 2017

von Yokoyama, K. | Kurita, N. | Fukuma, S. | +5

73

Management of phosphorus load in CKD patients

enthalten in: Clinical and experimental nephrology | 2017

von Taketani, Y. | Koiwa, F. | Yokoyama, K.

74

Preventive Strategies for Vascular Calcification in Patients with Chronic Kidney Disease

enthalten in: Contributions to nephrology | 2017

von Shigematsu, T. | Sonou, T. | Ohya, M. | +9

75

Successful Treatment of Plasma Cell-Rich Acute Rejection Using Pulse Steroid Therapy Alone : A Case Report

enthalten in: Case reports in transplantation | 2017

von Komatsuzaki, Y. | Nakada, Y. | Yamamoto, I. | +15

76

An introduction to CKD-MBD research: restart for the future

enthalten in: Clinical and experimental nephrology | 2017

von Fukagawa, M. | Inaba, M. | Yokoyama, K. | +3

77

An introduction to CKD-MBD research: restart for the future

enthalten in: Clinical and experimental nephrology | 2017

von Fukagawa, M. | Inaba, M. | Yokoyama, K. | +3

78

An introduction to CKD-MBD research: restart for the future

enthalten in: Clinical and experimental nephrology | 2017

von Fukagawa, M. | Inaba, M. | Yokoyama, K. | +3

79

A phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of etelcalcetide (ONO-5163/AMG 416), a novel intravenous calcimimetic, for secondary hyperparathyroidism in Japanese haemodialysis patients

enthalten in: Nephrology, dialysis, transplantation | 2017

von Fukagawa, M. | Yokoyama, K. | Shigematsu, T. | +5

80

Efficacy and safety of sucroferric oxyhydroxide compared with sevelamer hydrochloride in Japanese haemodialysis patients with hyperphosphataemia: A randomized, open‐label, multicentre, 12‐week phase III study

enthalten in: Nephrology | 2017

von Koiwa, F. | Yokoyama, K. | Fukagawa, M. | +2